CareDx Announces Finalization of Solid Organ Transplant Molecular Testing Local Coverage DeterminationBusiness Wire • 07/16/26
CareDx: The Transplant Platform Is Becoming A Specialty Diagnostics CompounderSeeking Alpha • 07/07/26
CareDx Completes Acquisition of Naveris, Extending Leadership into High-Growth Specialty OncologyBusiness Wire • 07/01/26
CareDx Announces Completion of Sale of Lab Products Business to Eurobio ScientificBusiness Wire • 06/30/26
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant CongressBusiness Wire • 06/18/26
CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of NephrologyBusiness Wire • 06/16/26
CareDx, Inc. (CDNA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/08/26
CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance TestingBusiness Wire • 04/28/26
CareDx Announces Presentation of More Than 50 Abstracts Including 16 Oral Presentations at the International Society for Heart and Lung Transplantation's 46th Annual MeetingBusiness Wire • 04/21/26
CareDx Launches AlloSeq Nano for High-Resolution Rapid HLA TypingZacks Investment Research • 04/21/26
CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read SequencingBusiness Wire • 04/20/26